Insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 23903296)

Published in J Atheroscler Thromb on August 01, 2013

Authors

Graziana Lupattelli1, Stefano De Vuono, Marcello Boni, Rony Helou, Massimo Raffaele Mannarino, Anna Rita Roscini, Abdalkader Alaeddin, Matteo Pirro, Gaetano Vaudo

Author Affiliations

1: Internal Medicine, Angiology and Atherosclerosis, Department of Clinical and Experimental Medicine, University of Perugia.

Articles by these authors

Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension (2007) 2.93

Obstructive sleep apnea syndrome. Eur J Intern Med (2012) 2.65

Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. Arterioscler Thromb Vasc Biol (2005) 1.57

Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation (2009) 1.56

Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension. J Hypertens (2004) 1.56

Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol (2004) 1.47

Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Intern Med (2006) 1.44

Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension. J Hypertens (2011) 1.43

CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation (2004) 1.36

Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol (2002) 1.31

The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19

Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol (2012) 1.19

Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr (2007) 1.15

Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension (2006) 1.13

Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens (2007) 1.10

Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension (2008) 1.09

Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study. Atherosclerosis (2005) 1.09

Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens (2003) 1.08

Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension (2005) 1.07

Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism (2004) 1.03

Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci (2005) 1.01

Laparoscopic adjustable gastric banding via pars flaccida versus perigastric positioning: technique, complications, and results in 2,549 patients. Surg Endosc (2010) 1.00

Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension (2006) 1.00

Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors. Ann N Y Acad Sci (2007) 0.99

Age-specific relationship of aortic pulse wave velocity with left ventricular geometry and function in hypertension. Hypertension (2007) 0.97

Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res (Hoboken) (2010) 0.94

Endothelial injury and repair: a novel theory for atherosclerosis. Angiology (2008) 0.93

Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis (2011) 0.92

Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis (2005) 0.90

Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutr Metab Cardiovasc Dis (2006) 0.90

Prognostic value of low and high ankle-brachial index in hospitalized medical patients. Eur J Intern Med (2011) 0.89

C-reactive protein in hypertension: clinical significance and predictive value. Nutr Metab Cardiovasc Dis (2006) 0.88

miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease. Neurobiol Aging (2013) 0.88

Diffuse muscoskeletal pain and proximal myopathy: do not forget hypovitaminosis D. J Clin Rheumatol (2010) 0.87

Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis (2009) 0.87

Prostaglandin E1 improves endothelial function in critical limb ischemia. J Cardiovasc Pharmacol (2003) 0.86

Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment. Ann Rheum Dis (2012) 0.85

Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia. Metabolism (2003) 0.84

Assessing cardiovascular risk: should we discard diastolic blood pressure? Circulation (2009) 0.84

Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study). Am J Cardiol (2003) 0.83

Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Metabolism (2007) 0.83

Molecular biology of atherosclerosis. Clin Cases Miner Bone Metab (2008) 0.83

A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias. J Clin Lipidol (2012) 0.83

Osteoanabolic therapy: a non-surgical option of treatment for Kümmell's disease? Rheumatol Int (2010) 0.83

Transient osteoporosis of the hip: successful treatment with teriparatide. Rheumatol Int (2010) 0.82

Artichoke juice improves endothelial function in hyperlipemia. Life Sci (2004) 0.82

IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81

Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias. J Pediatr (2011) 0.80

Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J Cardiovasc Pharmacol Ther (2009) 0.80

Left ventricular hypertrophy reversal and prevention of diabetes: two birds with one stone? Hypertension (2007) 0.80

Human endothelial impairment in sepsis. Atherosclerosis (2007) 0.80

Increased postprandial lipemia in patients with normolipemic peripheral arterial disease. Am Heart J (2002) 0.80

Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. J Rheumatol (2007) 0.80

Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias. Metabolism (2003) 0.79

Effect of body weight changes on 24-hour blood pressure and left ventricular mass in hypertension: a 4-year follow-up. Am J Hypertens (2003) 0.79

Carotid intima-media thickness and bone turnover: the role of C-terminal telopeptide of type I collagen. Intern Emerg Med (2010) 0.79

Prognostic value of elevated white blood cell count in hypertension. Am J Hypertens (2007) 0.79

A systematic review and meta-analysis of controlled trials on the effects of statin and fibrate therapies on plasma homocysteine levels. Curr Med Chem (2016) 0.79

Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia. Life Sci (2012) 0.78

The use of osteopathic manipulative treatment as adjuvant therapy in patients with peripheral arterial disease. Man Ther (2008) 0.78

Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia. Am J Cardiol (2002) 0.78

Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. Metabolism (2008) 0.78

Racial difference in endothelial function: role of the infective burden. Atherosclerosis (2006) 0.78

Heat-shock protein 65 autoantibodies are differently associated with early atherosclerosis in rheumatoid arthritis and in healthy subjects. Ann N Y Acad Sci (2007) 0.77

An endogenous brake on the sympathetic nervous system: the emerging role of catestatin in hypertension. J Cardiovasc Med (Hagerstown) (2011) 0.77

Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: comment on the article by Farragher et al. Arthritis Rheum (2009) 0.77

Intragastric gastric band migration: erosion: an analysis of multicenter experience on 177 patients. Surg Endosc (2012) 0.77

Acute inflammatory state during influenza infection and endothelial function. Atherosclerosis (2005) 0.77

Effects of atorvastatin on electrophoretic characteristics of LDL particles among subjects with heterozygous familial hypercholesterolemia. Atherosclerosis (2003) 0.77

Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. Ann N Y Acad Sci (2005) 0.76

Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study). Obes Surg (2014) 0.76

Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr Pharm Des (2016) 0.76

Adiponectin and hypertension: the connection lies within the fat. Am J Hypertens (2008) 0.75

Long-term weight loss and blood pressure reduction: the perfect is the enemy of the good. Am J Hypertens (2006) 0.75

Hypoadiponectinemia: a novel link between obesity and hypertension? Hypertension (2007) 0.75

Serum triglyceride concentration and coronary heart disease. Circulation (2002) 0.75

Endothelial microparticles and arterial stiffness: casual coincidence or causative culprit? Am J Hypertens (2007) 0.75

Treating hypertensive non-dippers: additional benefit from nocturnal blood pressure reduction? Cardiovasc Drugs Ther (2005) 0.75

Osteoporosis in men: other secondary causes. Joint Bone Spine (2009) 0.75

Determinants of the ambulatory arterial stiffness index regression line. Hypertension (2009) 0.75

The emerging role of atherosclerotic cardiovascular disease in systemic lupus erythematosus. Nutr Metab Cardiovasc Dis (2009) 0.75

Irbesartan for heart failure with preserved ejection fraction. N Engl J Med (2009) 0.75